Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.410
-0.020 (-1.40%)
At close: Dec 10, 2025, 4:00 PM EST
1.410
0.00 (-0.03%)
After-hours: Dec 10, 2025, 7:23 PM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $48.48 million as of December 10, 2025. Its market cap has decreased by -63.37% in one year.
Market Cap
48.48M
Enterprise Value
40.73M
1-Year Change
-63.37%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $48.48M, a decrease of -76.61%. That is a compound annual growth rate of -54.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 49.16M | -59.89% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |